<?xml version="1.0" encoding="UTF-8"?>
<ref id="B18">
 <label>18.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Zhang</surname>
    <given-names>W</given-names>
   </name>, 
   <name name-style="western">
    <surname>Zhao</surname>
    <given-names>Y</given-names>
   </name>, 
   <name name-style="western">
    <surname>Zhang</surname>
    <given-names>F</given-names>
   </name>, 
   <name name-style="western">
    <surname>Wang</surname>
    <given-names>Q</given-names>
   </name>, 
   <name name-style="western">
    <surname>Li</surname>
    <given-names>T</given-names>
   </name>, 
   <name name-style="western">
    <surname>Liu</surname>
    <given-names>Z</given-names>
   </name>, 
   <name name-style="western">
    <surname>Wang</surname>
    <given-names>J</given-names>
   </name>, 
   <name name-style="western">
    <surname>Qin</surname>
    <given-names>Y</given-names>
   </name>, 
   <name name-style="western">
    <surname>Zhang</surname>
    <given-names>X</given-names>
   </name>, 
   <name name-style="western">
    <surname>Yan</surname>
    <given-names>X</given-names>
   </name>, 
   <name name-style="western">
    <surname>Zeng</surname>
    <given-names>X</given-names>
   </name>, 
   <name name-style="western">
    <surname>Zhang</surname>
    <given-names>S</given-names>
   </name>
  </person-group>
  <year>2020</year>
  <article-title>The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): the perspectives of clinical immunologists from China</article-title>. 
  <source>Clin Immunol</source>
  <volume>214</volume>:
  <fpage>108393</fpage>. doi:
  <pub-id pub-id-type="doi">10.1016/j.clim.2020.108393</pub-id>.
  <pub-id pub-id-type="pmid">32222466</pub-id>
 </mixed-citation>
</ref>
